The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates ERK1, is expressed in a variety of tissues with the highest levels in pancreas and brain, and is localized in the nucleus. [provided by RefSeq, Jul 2008].
Cai, Chen, Han, He, Chen, Chen, Yang, Wu, Zeng, Zou, Liang, Dai, Jiang, Zhong: "Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer." in: International journal of clinical and experimental medicine, Vol. 8, Issue 3, pp. 4186-94, (2015) (PubMed).
Fan, Geurts, Pabbidi, Smith, Harder, Jacob, Roman: "Zinc-finger nuclease knockout of dual-specificity protein phosphatase-5 enhances the myogenic response and autoregulation of cerebral blood flow in FHH.1BN rats." in: PLoS ONE, Vol. 9, Issue 11, pp. e112878, (2014) (PubMed).
Mandl, Slack, Keyse: "Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5." in: Molecular and cellular biology, Vol. 25, Issue 5, pp. 1830-45, (2005) (PubMed).
Ueda, Arakawa, Nakamura: "Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53." in: Oncogene, Vol. 22, Issue 36, pp. 5586-91, (2003) (PubMed).